Detalhe da pesquisa
1.
CDK12 inhibition upregulates ATG7 triggering autophagy via AKT/FOXO3 pathway and enhances anti-PD-1 efficacy in colorectal cancer.
Pharmacol Res
; 201: 107097, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38354870
2.
ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy.
J Transl Med
; 21(1): 605, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679788
3.
Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway.
J Pharmacol Exp Ther
; 380(1): 15-25, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740946
4.
The discovery of a novel series of potential ERRα inverse agonists based on p-nitrobenzenesulfonamide template for triple-negative breast cancer in vivo.
J Enzyme Inhib Med Chem
; 37(1): 125-134, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894977
5.
Reduced emergency room visits and improved medication adherence of an integrated oncology pharmaceutical care practice in China.
J Oncol Pharm Pract
; 27(6): 1503-1515, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162249
6.
Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients.
BMC Cancer
; 18(1): 1038, 2018 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30359238
7.
Determination of telbivudine in the plasma of chronic hepatitis B patients in long-term treatment by high-performance liquid chromatographic-tandem mass spectrometry.
Biomed Chromatogr
; 32(4)2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29148589
8.
Antiproliferative activity of Farnesol in HeLa cervical cancer cells is mediated via apoptosis induction, loss of mitochondrial membrane potential (ΛΨm) and PI3K/Akt signalling pathway.
J BUON
; 23(3): 752-757, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30003747
9.
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(12): 1637-1651, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29103871
10.
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial.
Lancet Oncol
; 16(8): 990-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26159065
11.
Tectorigenin regulates adipogenic differentiation and adipocytokines secretion via PPARγ and IKK/NF-κB signaling.
Pharm Biol
; 53(11): 1567-75, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25856699
12.
[XCT790 inhibits rat vascular smooth muscle cells proliferation through down-regulating the expression of estrogen-related receptor alpha].
Yao Xue Xue Bao
; 49(2): 190-7, 2014 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-24761608
13.
STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapy.
J Chemother
; 36(1): 61-71, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151185
14.
Multifunctional coatings fabricated from Chinese hemp-derived superhydrophobic micro-nanocellulose.
Int J Biol Macromol
; 263(Pt 2): 130430, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403218
15.
Carfilzomib suppressed LDHA-mediated metabolic reprogramming by targeting ATF3 in esophageal squamous cell carcinoma.
Biochem Pharmacol
; 219: 115939, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38000560
16.
Clinical outcomes and medical resource utilization of toripalimab combination therapy versus bevacizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer.
Curr Med Res Opin
; 40(3): 441-453, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193524
17.
SIRT6 deficiency causes ovarian hypoplasia by affecting Plod1-related collagen formation.
Aging Cell
; 23(2): e14031, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936548
18.
The impact of the COVID-19 pandemic on dietary behaviors among school-age children, adolescents, and young adults: a systematic review and meta-analysis.
Nutr Rev
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820346
19.
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours.
Invest New Drugs
; 31(1): 108-14, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415795
20.
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.
Invest New Drugs
; 31(3): 677-84, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22843211